Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term carcinoma. Found 315 abstracts

no pagination
Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol. 2018 May;199(5):1238-44.
Haifler M, Ristau BT, Higgins AM, Smaldone MC, Kutikov A, Zisman A, Uzzo RG. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2018 Mar;199(3):649-54.
Sonpavde GP, Mariani L, Lo Vullo S, Raggi D, Giannatempo P, Bamias A, Crabb SJ, Bellmunt J, Yu EY, Niegisch G, Vaishampayan UN, Theodore C, Berthold DR, Srinivas S, Sridhar SS, Plimack ER, Rosenberg JE, Powles T, Galsky MD, Necchi A. Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma. J Urol. 2018 Dec;200(6):1207-14.
Haifler M, Ristau BT, Higgins AM, Smaldone MC, Kutikov A, Zisman A, Uzzo RG. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2017 Sep 20;.
Ito T, Derweesh IH, Ginzburg S, Abbosh PH, Raheem OA, Mirheydar H, Hamilton Z, Chen DY, Smaldone MC, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017 Jan;197(1):31-6.
Ito T, Derweesh IH, Ginzburg S, Abbosh PH, Raheem OA, Mirheydar H, Hamilton Z, Chen DY, Smaldone MC, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017 Jan;197(1):31-6.
Perera M, Al-Hebshi NN, Perera I, Ipe D, Ulett GC, Speicher DJ, Chen T, Johnson NW. A dysbiotic mycobiome dominated by Candida albicans is identified within oral squamous-cell carcinomas. Journal of oral microbiology. 2017 Oct;9(1):1385369.   PMCID: PMC5678454
Zou ZW, Ma C, Medoro L, Chen L, Wang B, Gupta R, Liu T, Yang XZ, Chen TT, Wang RZ, Zhang WJ, Li PD. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells. Oncotarget. 2016 Aug 20;.
Zou ZW, Ma C, Medoro L, Chen L, Wang B, Gupta R, Liu T, Yang XZ, Chen TT, Wang RZ, Zhang WJ, Li PD. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells. Oncotarget. 2016 Aug 20;7(38):61741-54.   PMCID: PMC5308687
Zou ZW, Ma C, Medoro L, Chen L, Wang B, Gupta R, Liu T, Yang XZ, Chen TT, Wang RZ, Zhang WJ, Li PD. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells. Oncotarget. 2016 Sep 20;7(38):61741-54.   PMCID: PMC5308687
Minervini A, Campi R, Kutikov A, Montagnani I, Sessa F, Serni S, Raspollini MR, Carini M. Histopathological Validation of the Surface-Intermediate-Base Margin Score for Standardized Reporting of Resection Technique during Nephron Sparing Surgery. J Urol. 2015 Oct;194(4):916-22.
Ginzburg S, Uzzo R, Al-Saleem T, Dulaimi E, Walton J, Corcoran A, Plimack E, Mehrazin R, Tomaszewski J, Viterbo R, Chen DY, Greenberg R, Smaldone M, Kutikov A. Coexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal Biopsy. Journal of Urology. 2014 Feb;191(2):296-300.   PMCID: PMC4083459
Mehrazin R, Smaldone MC, Kutikov A, Li T, Tomaszewski JJ, Canter DJ, Viterbo R, Greenberg RE, Chen DY, Uzzo RG. Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol. 2014 Sep;192(3):659-64.   PMCID: 4419692
Mu ZM, Li H, Fernandez SV, Alpaugh KR, Zhang RG, Cristofanilli M. EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells. Journal of Experimental & Clinical Cancer Research. 2013 Sep;32:70.   PMCID: PMC 3850122
Betancourt AM, Wang J, Jenkins S, Mobley J, Russo J, Lamartiniere CA. Altered Carcinogenesis and Proteome in Mammary Glands of Rats after Prepubertal Exposures to the Hormonally Active Chemicals Bisphenol A and Genistein. Journal of Nutrition. 2012 Jul;142(7):1382S-1388S.   PMCID: PMC3374674
Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, Benitez J, Garcia MJ, Neuhausen S, Gail MH, Hartge P, Peock S, Frost D, Evans G, Eeles R, Godwin AK, Daly MB, Kwong A, Ma ES, Lazaro C, Blanco I, Montagna M, D'Andrea E, Nicoletto MO, Johnatty SE, Kruger S, Jensen A, Hogdall E, Goode EL, Fridley BL, Loud JT, Greene MH, Mai PL, Chetrit A, Lubin F, Hirsh-Yechezkel G, Glendon G, Andrulis IL, Toland AE, Senter L, Gore ME, Gourley C, Michie CO, Song HL, Tyrer J, Whittemore AS, McGuire V, Sieh W, Kristoffersson U, Olsson H, Borg A, Levine DA, Steele L, Beattie MS, Chan S, Nussbaum RL, Moysich KB, Gross J, Cass I, Walsh C, Li AJ, Leuchter R, Gordon O, Garcia-Closas M, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PD. Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer. JAMA-Journal of the American Medical Association. 2012 Jan;307(4):382-90.
Chen XM, Cvetkovic D, Ma CM, Chen LL. Quantitative study of focused ultrasound enhanced doxorubicin delivery to prostate tumor in vivo with MRI guidance. Medical Physics. 2012 May;39(5):2780-6.
Chu CS, Boyer J, Schullery DS, Gimotty PA, Gamerman V, Bender J, Levine BL, Coukos G, Rubin SC, Morgan MA, Vonderheide RH, June CH. Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission. Cancer Immunology Immunotherapy. 2012 May;61(5):629-41.
Coleman RL, Sill MW, Lankes HA, Fader AN, Finkler NJ, Hoffman JS, Rose PG, Sutton GP, Drescher CW, McMeekin DS, Hu W, Deavers M, Godwin AK, Alpaugh RK, Sood AK. A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study. Gynecologic Oncology. 2012 Dec;127(3):538-43.   PMCID: PMC3568489
Dees EC, Cohen RB, von Mehren M, Stinchcombe TE, Liu H, Venkatakrishnan K, Manfredi M, Fingert H, Burris HA, Infante JR. Phase I Study of Aurora A Kinase Inhibitor MLN8237 in Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics, and Bioavailability of Two Oral Formulations. Clinical Cancer Research. 2012 Sep;18(17):4775-84.   PMCID: Private funding
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term carcinoma

carcinoma renal cell nephrectomy LncRNA ANRIL glucose metabolism Aged kidney pathology Middle Aged mTOR pathway breast-cancer cisplatin Treatment Outcome mathematical concepts 80 and over Aged cell carcinoma Female mortality Kidney Neoplasms aspirin survival Male clopidogrel squamous cell theoretical risk nasopharyngea Adult expression models hemorrhage her-2 Coronary Thrombosis Antisense Oligonucleotides polymerase gene-expression Postoperative Hemorrhage percutaneous biopsy Tumor Burden Endometrial cancer Aflibercept-VEGF Trap-Toxicity-Fibroblast growth factor Dendritic cell Ovarian cancer-Vaccine-Clinical trial-Consolidation therapy needle core biopsy combination oxyphilic Cancer stem cell adverse effects Renal Cell Carcinoma prognosis marker radical nephrectomy target bladder-cancer t1b immunotherapy leukemia brain in-utero exposure peptide DNA ribosomal spacer Aspirin solid tumors Inflammatory breast cancer Up-Regulation experience metabolism tumor-associated antigen immune-response Neoplastic Stem Cells high-throughput nucleotide sequencing Glycolysis nonsense watchful waiting progesterone-receptor model Age Factors epidemiology adriamycin vegf aneuploidy Disease Progression surgery EZH2 Multivariate Analysis validation studies morbidity lymphocytes kidney neoplasms Patient Readmission identification lymph node excision Carcinoma Fungi mycobiome Kinetics epithelial-cells tumor subtypes formation rats Tumor Biomarkers urinary tract features Young Adult chemotherapy parenchymal volume etiology genetics neu accuracy susceptibility gene cytology modulation Perioperative Period selective inhibitor doxorubicin Neoplastic Gene Expression Regulation tumors regulatory t-cells statistics & numerical data Tumor spheroid Retrospective Studies competing small-molecule inhibitor carriers Blood Transfusion Exons annexin-ii menstrual factors disruption proteins outcomes penile neoplasms disease progression consortium low-grade urothelium Long Noncoding RNA parameter Watchful Waiting Surgical Blood Loss Nephrectomy mouth stem-cells inhibition tumor Risk Factors endothelial growth-factor Side-Population Cells microbiome 1993 en ll-ultrasound in medicine and biology-v19-p67
Last updated on Monday, November 04, 2019